Search bioRxiv⌕ Search

Biology subjects

Malkov, V.

Publications and source records attributed to Malkov, V..

2 recordsLinked to original sources

OmiXAI: An Ensemble XAI Pipeline for Interpretable Deep Learning in Omics Data

Deep learning methods have become methods of choice in the analysis of genomic data. The performance of deep learning models depends on the information available for training. A growing trend in deep learning applications involves leveraging multi-omics data--spanning genomics, transcriptomics, epigenomics, proteomics, metabolomics, and other domains. When a deep learning model trained on omics data achieves high performance, the important question is to define factors that contribute to models predictive power. Explainable AI (XAI) methods can be categorized as model-aware and model-agnostic. Model-agnostic approaches, which rely on combinatorial feature perturbations to assess impact, are often computationally prohibitive for deep learning models. To address this, we developed OmiXAI, a pipeline integrating ensemble model-aware XAI methods. Our framework incorporates gradient-based techniques--including Integrated Gradients, InputXGradients, Guided Backpropagation, and Deconvolution (for CNNs and GNNs)--as well as Saliency Maps and GNNExplainer (specifically for GNNs). We evaluated OmiXAI on Z-DNA prediction using multi-omics features, demonstrating its efficacy through feature importance analysis and benchmarking of XAI methods. Notably, OmiXAI enabled feature engineering, reducing the critical feature set from almost 2,000 to just 50. Its modular design allows seamless integration of additional attribution methods, ensuring adaptability beyond omics to diverse problem domains. While testing the ensemble approach we benchmarked individual XAI methods and discuss their drawbacks and limitations. OmiXAI is freely available at https://github.com/aameliig/OmiXAI.

bioinformatics↗

Rare disruptive variants in the DISC1 Interactome and Regulome: association with cognitive ability and schizophrenia

Schizophrenia (SCZ), bipolar disorder (BD) and recurrent major depressive disorder (rMDD) are common psychiatric illnesses. All have been associated with lower cognitive ability, and show evidence of genetic overlap and substantial evidence of pleiotropy with cognitive function and neuroticism. Disrupted in schizophrenia 1 (DISC1) protein directly interacts with a large set of proteins (DISC1 Interactome) that are involved in brain development and signaling. Modulation of DISC1 expression alters the expression of a circumscribed set of genes (DISC1 Regulome) that are also implicated in brain biology and disorder. Here, we report targeted sequencing of 59 DISC1 Interactome genes and 154 Regulome genes in 654 psychiatric patients and 889 cognitively-phenotyped control subjects, on whom we previously reported evidence for trait association from complete sequencing of the DISC1 locus. Burden analyses of rare and singleton variants predicted to be damaging were performed for psychiatric disorders, cognitive variables and personality traits. The DISC1 Interactome and Regulome showed differential association across the phenotypes tested. After family-wise error correction across all traits (FWERacross), an increased burden of singleton disruptive variants in the Regulome was associated with SCZ (FWERacross P=0.0339). The burden of singleton disruptive variants in the DISC1 Interactome was associated with low cognitive ability at age 11 (FWERacross P=0.0043). These results suggest that variants in the DISC1 Interactome effect the risk of psychiatric illness through altered expression of schizophrenia-associated genes. The biological impact of rare variants highlighted here merit further study.

genetics↗